» Articles » PMID: 27092276

Current Data on Risk Factor Estimates Does Not Explain the Difference in Rates of Melanoma Between Hispanics and Non-Hispanic Whites

Overview
Journal J Skin Cancer
Publisher Wiley
Specialty Dermatology
Date 2016 Apr 20
PMID 27092276
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

United States Hispanics have seven times lower melanoma incidence rates than non-Hispanic whites (NHW). It is unclear whether this difference can be explained solely by phenotypic risk factors, like darker skin, or whether modifiable risk factors, like sun exposure, also play a role. The purpose of this paper is to summarize what is currently known about melanoma risk factors among Hispanics and NHWs, and whether or not those differences could explain the difference in melanoma incidence. Through literature review, relative risks and prevalence of melanoma risk factors in Hispanics and NHWs were identified and used to calculate the expected rate in Hispanics and rate ratio compared to NHWs. We found that melanoma risk factors either have similar frequency in Hispanics and NHWs (e.g., many large nevi) or are less frequent in Hispanics but do not explain a high proportion of disease variation (e.g., red hair). Considering current knowledge of risk factor prevalence, we found that melanoma incidence rates in the two groups should actually be similar. Sun exposure behavior among Hispanics may contribute to the explanation for the 7-fold difference in melanoma rates. Currently, limited data exist on sun exposure behavior among Hispanics, but possibilities for improving primary prevention by further studying these practices are substantial.

Citing Articles

Combinatorial immunotherapy for melanoma.

George D, Armenio V, Katz S Cancer Gene Ther. 2016; 24(3):141-147.

PMID: 27834353 DOI: 10.1038/cgt.2016.56.


Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility.

Marzagalli M, Montagnani Marelli M, Casati L, Fontana F, Moretti R, Limonta P Front Endocrinol (Lausanne). 2016; 7:140.

PMID: 27833586 PMC: 5080294. DOI: 10.3389/fendo.2016.00140.


CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma.

Su J, Gao T, Jiang M, Wu L, Zeng W, Zhao S Oncotarget. 2016; 7(40):64778-64784.

PMID: 27556188 PMC: 5323115. DOI: 10.18632/oncotarget.11415.

References
1.
Fargnoli M, Piccolo D, Altobelli E, Formicone F, Chimenti S, Peris K . Constitutional and environmental risk factors for cutaneous melanoma in an Italian population. A case-control study. Melanoma Res. 2004; 14(2):151-7. DOI: 10.1097/00008390-200404000-00013. View

2.
Grulich A, Bataille V, Swerdlow A, Newton-Bishop J, Cuzick J, Hersey P . Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia. Int J Cancer. 1996; 67(4):485-91. DOI: 10.1002/(SICI)1097-0215(19960807)67:4<485::AID-IJC4>3.0.CO;2-O. View

3.
de Vries E, Boniol M, Severi G, Eggermont A, Autier P, Bataille V . Public awareness about risk factors could pose problems for case-control studies: the example of sunbed use and cutaneous melanoma. Eur J Cancer. 2005; 41(14):2150-4. DOI: 10.1016/j.ejca.2005.04.042. View

4.
Klepp O, MAGNUS K . Some environmental and bodily characteristics of melanoma patients. A case-control study. Int J Cancer. 1979; 23(4):482-6. DOI: 10.1002/ijc.2910230407. View

5.
Mitra D, Luo X, Morgan A, Wang J, Hoang M, Lo J . An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature. 2012; 491(7424):449-53. PMC: 3521494. DOI: 10.1038/nature11624. View